- Language: English
- 569 Pages
- Published: December 2014
- Region: Global
U.S. Botulinum Toxin Emerging Markets
- ID: 364490
- February 2003
- Region: United States
- Frost & Sullivan
Under-Treated Disease States Create Strong Market Opportunity for Off-Label Use of Botulinum Toxin
The clinically proven efficacy of botulinum toxin in under-treated disease states such as pain management, spasticity, and primary and secondary focal dystonia is expected to significantly increase its off-label use in these categories. Indeed, botulinum toxin has relied on off-label sales to drive revenues for many years.
Since current treatment options are few and have limited efficacy, several pharmaceutical companies are expected to target under-treated disease states, as they offer tremendous revenue potential, scope for market expansion, and high growth.
This Frost & Sullivan research is an in-depth analysis of the emerging markets for botulinum toxin in the United States, divided into the non-surgical cosmetic segment and the therapeutic segment. This report discusses major drivers, restraints and challenges governing the market, competitive structure and competitor strategies, analyzes key candidates in clinical trials, besides providing detailed revenue, price, unit, and demand forecasts.
Botulinum Toxin Drives Demand for Prophylactic, Local, Non-systemic Lifestyle Drugs
Botulinum toxin is a unique and valuable treatment option for patients because it is prophylactic, local, and is known to enhance quality of life for debilitating disease states, says the analyst. The market is lucrative and relatively untapped. With many pharmaceutical companies focusing on lifestyle drugs, there is a growing trend toward prophylactic drugs that work by decreasing the frequency of symptom onset, especially for conditions such as migraine headaches, asthma, or chronic back pain.
Botulinum toxin is expected to drive the development of a new class of prophylactic, local drugs that answer the patient's need for reduced medication, side effects, and onset of symptoms. Preventing the onset of chronic conditions can further benefit patients by reducing the number of sick days and consequently, enhancing productivity.
Major Opportunities for Combination Therapy and Strategic Partnerships Exist
The versatility in the number of applications for botulinum toxin and the highly localized therapeutic focus make possible numerous combination treatments with oral, surgical, and physical therapy, notes the analyst. Large pharmaceutical companies, eager to extend the patent period of their blockbuster drugs and enter the lucrative botulinum toxin market, are targeting therapeutic areas such as migraine prevention and treatment, focal dystonia, and spasticity.
Combination therapy is also increasingly being used in the non-surgical cosmetic segment to yield optimal results for patients. Co-branding and strategic partnerships with other participants are other initiatives that will aid in successful market penetration as well as help minimize marketing associated costs.
SHOW LESS READ MORE >
2Report Scope and Segmentation
3Current Approved Indications for Botulinum Toxin
4Clinical Trials Involving Botulinum Toxin(s)
6Existing and Future Market Participants
1Market Drivers (Cosmetic and Therapeutic Segments)
2Market Restraints (Cosmetic and Therapeutic Segments)
3Challenge 1: Limited Product Differentiation Puts Downward Pressure on Prices
4Challenge 2 : Lax Industry Standards Incite More Stringent Regulatory Process Which Impedes Market Growth
5Challenge 3: Lack of Generic Competition Attracts New Entrants and Threatens Market Profit Potential
6Challenge 4 : U.S. Government Actions against Bioterrorism Threaten to Restrict Product Supply
C.Forecasts and Trends
3Market Engineering Analysis
4Market and Technology Trends
5New Technology Developments
1Competitive Structure and Competitor Strategies
3Market Share Analysis
3Botulinum Toxin Cosmetic Applications
2Non-Surgical Cosmetic Market Analysis
B.Forecasts and Market Trends
2Patient and Procedure Forecasts
3Pricing Analysis and Trends
5Market Share Analysis
6Market Engineering Analysis
7Combination Treatment Trends
4Botulinum Toxin Therapeutic Applications
2Botulinum Toxin Dystonia Market
3Botulinum Toxin Spasticity Market
4Botulinum Toxin Pain Management Market
B.Forecasts and Market Trends
1Patient and Procedure Forecasts
2Price Trends and Analysis
4Market Share Analysis
5Market Engineering Analysis
6Combination Treatment Trends